Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Lawrence Kleiman

Lady Davis Institute for Medical Research Jewish General Hospital, Canada

Title: Viral and host factors regulating the annealing of primer tRNALys3 to HIV-1 genomic RNA.

Biography

Biography: Lawrence Kleiman

Abstract

During HIV-1 infection, the conversion of the HIV-1 RNA genome into a double-stranded DNA that can be integrated into the host cell’s genome is accomplished by reverse transcription. The initiation of this reverse transcription requires a specific cellular tRNALys3 to act as a primer. This tRNA is annealed during assembly of new HIV-1, i.e., the infecting virus already contains annealed tRNALys3. The 3´ 18 nts of tRNALys3 anneal to a complementary 18nt sequences in the viral RNA termed the primer binding site (PBS), and in this presentation, we will discuss the cellular and viral factors that promote the ability of the tRNALys3 to locate the 18 nt sequence within the >9 KB comprising the HIV-1 viral RNA genome. This is associated with the formation of an early HIV-1 assembly intermediate at the site of the Gag/GagPol translation, whose components include Gag, GagPol, lysyl-tRNA synthetase (LysRS), and tRNALys3. This intermediate contains an increased concentration of tRNALys3 due to a specific interaction between viral Gag and LysRS, and is able to bind through LysRS to a viral RNA structure near the PBS that resembles tRNALys3 . This initial cytoplasmic annealing of tRNALys3 to viral RNA is part of a multi-staged annealing process, and not only functions in promoting reverse transcription, but also facilitates a conformation change in the 5´-untranslated region of viral RNA that promotes viral RNA dimerization.